These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 5939596)

  • 1. Skeletal muscle scans in progressive muscular dystrophy and related neuromuscular diseases.
    Nagai T; Furukawa T
    J Nucl Med; 1966 Jun; 7(6):474-6. PubMed ID: 5939596
    [No Abstract]   [Full Text] [Related]  

  • 2. [Histochemistry of skeletal muscle ATPase in neuromuscular diseases, with special reference to progressive muscular dystrophy].
    Tomonaga M; Muro T
    Igaku To Seibutsugaku; 1967 Jul; 75(1):32-6. PubMed ID: 4229920
    [No Abstract]   [Full Text] [Related]  

  • 3. Adenylosuccinase in human muscular dystrophy.
    Kar NC; Pearson CM
    Muscle Nerve; 1981; 4(2):174-5. PubMed ID: 7207508
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platelet-derived growth factor and its receptors are related to the progression of human muscular dystrophy: an immunohistochemical study.
    Zhao Y; Haginoya K; Sun G; Dai H; Onuma A; Iinuma K
    J Pathol; 2003 Sep; 201(1):149-59. PubMed ID: 12950028
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human muscle carbonic anhydrase III (CA-III). Purification, immunohistochemical localization in the human skeletal muscle and its clinical application to the neuromuscular disease.
    Shima K
    Hokkaido Igaku Zasshi; 1984 Mar; 59(2):98-116. PubMed ID: 6430772
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Sideremia and muscular myoglobin in progressive muscular dystrophy and other neuromuscular diseases].
    Buscaino GA
    Acta Neurol (Napoli); 1966; 21(1):26-32. PubMed ID: 5999243
    [No Abstract]   [Full Text] [Related]  

  • 7. Malignant hyperthermia and related neuromuscular diseases: caffeine contracture of the skinned muscle fibers.
    Takagi A; Sunohara N; Ishihara T; Nonaka I; Sugita H
    Muscle Nerve; 1983 Sep; 6(7):510-4. PubMed ID: 6633564
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevated basic fibroblast growth factor in the serum of patients with Duchenne muscular dystrophy.
    D'Amore PA; Brown RH; Ku PT; Hoffman EP; Watanabe H; Arahata K; Ishihara T; Folkman J
    Ann Neurol; 1994 Mar; 35(3):362-5. PubMed ID: 8122890
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum enzymes in muscular dystrophy and certain other muscular and neuromuscular diseases. I. Serum glutamic oxalacetic transaminase.
    PEARSON CM
    N Engl J Med; 1957 Jun; 256(23):1069-75. PubMed ID: 13451996
    [No Abstract]   [Full Text] [Related]  

  • 10. Expression of transforming growth factor-beta 1 and its relation to endomysial fibrosis in progressive muscular dystrophy.
    Yamazaki M; Minota S; Sakurai H; Miyazono K; Yamada A; Kanazawa I; Kawai M
    Am J Pathol; 1994 Feb; 144(2):221-6. PubMed ID: 8311110
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Fluorescence histochemical study of catecholamine concentrations in the skeletal muscles of patients with different forms of progressive neuromuscular disease].
    Temin PA; Dzhabarov BD; Grinio LP; Kargina-Terent'eva RA; Parshikova MV
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1982; 82(3):31-4. PubMed ID: 7080773
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunocytochemical studies of cathepsin D in human skeletal muscle.
    Whitaker JN; Bertorini TE; Mendell JR
    Ann Neurol; 1983 Feb; 13(2):133-42. PubMed ID: 6338808
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral health considerations in muscular dystrophies.
    Balasubramaniam R; Sollecito TP; Stoopler ET
    Spec Care Dentist; 2008; 28(6):243-53. PubMed ID: 19068065
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Dystrophin detection by immunofluorescent technique for diagnosing muscular dystrophy].
    Wang X; Xie Y; Zhang C; Liu Z
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2002 Jun; 19(3):239-42. PubMed ID: 12048687
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dysferlin and the plasma membrane repair in muscular dystrophy.
    Bansal D; Campbell KP
    Trends Cell Biol; 2004 Apr; 14(4):206-13. PubMed ID: 15066638
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Muscle fiber degeneration and necrosis in muscular dystrophy and other muscle diseases: cytochemical and immunocytochemical data.
    Cornelio F; Dones I
    Ann Neurol; 1984 Dec; 16(6):694-701. PubMed ID: 6524876
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Analysis of the interference pattern in patients with muscular dystrophy].
    Escobar-Cedillo RE; Miranda A; Lona S; Castillo M
    Rev Neurol; 2004 Sep 16-30; 39(6):517-20. PubMed ID: 15467987
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of the cerebrospinal fluid and blood serum of patients with progressive muscular dystrophy on frog nerve-muscle preparation].
    SEDIARI F; MORETTI E
    Boll Soc Ital Biol Sper; 1954; 30(1-2):92-3. PubMed ID: 13190050
    [No Abstract]   [Full Text] [Related]  

  • 19. [Association between dystrophin and neuronal nitric oxide synthase in muscles of progressive muscular dystrophy].
    Wang S; Shen D
    Zhonghua Yi Xue Za Zhi; 2002 Feb; 82(3):155-7. PubMed ID: 11953148
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intramuscular renin-angiotensin system is activated in human muscular dystrophy.
    Sun G; Haginoya K; Dai H; Chiba Y; Uematsu M; Hino-Fukuyo N; Onuma A; Iinuma K; Tsuchiya S
    J Neurol Sci; 2009 May; 280(1-2):40-8. PubMed ID: 19232644
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.